Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Deconstructing the autism concept and its semantics.

Graf WD.

Dev Med Child Neurol. 2019 Jul 4. doi: 10.1111/dmcn.14312. [Epub ahead of print] No abstract available.

PMID:
31273752
2.

Exome Sequencing and Molecular Diagnosis.

Graf WD.

Dtsch Arztebl Int. 2019 Mar 22;116(12):195-196. doi: 10.3238/arztebl.2019.0195. No abstract available.

3.

Lawful physician-hastened death: AAN position statement.

Russell JA, Epstein LG, Bonnie RJ, Conwit R, Graf WD, Kirschen M, Kurek JA, Larriviere DG, Pascuzzi RM, Rizzo M, Sattin JA, Simmons Z, Taylor L, Tsou A, Williams MA; Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS); Ethics, Law and Humanities Committee, a joint committee of the AAN, ANA and CNS.

Neurology. 2018 Feb 27;90(9):420-422. doi: 10.1212/WNL.0000000000005012. No abstract available.

4.

Author response: The autism "epidemic": Ethical, legal, and social issues in a developmental spectrum disorder.

Graf WD, Miller G, Epstein LG, Rapin I.

Neurology. 2017 Sep 19;89(12):1310-1311. doi: 10.1212/WNL.0000000000004406. No abstract available.

PMID:
28923889
5.

Stem cell transplantation in Krabbe disease: New truths discovered and opinions change.

Graf WD.

Neurology. 2017 Sep 26;89(13):1318-1319. doi: 10.1212/WNL.0000000000004427. Epub 2017 Aug 30. No abstract available.

PMID:
28855407
6.

The autism "epidemic": Ethical, legal, and social issues in a developmental spectrum disorder.

Graf WD, Miller G, Epstein LG, Rapin I.

Neurology. 2017 Apr 4;88(14):1371-1380. doi: 10.1212/WNL.0000000000003791. Epub 2017 Mar 8. Review.

PMID:
28275086
7.
8.

Communicating Concern about Early Signs of Autism to Parents.

Graf WD.

AMA J Ethics. 2015 Apr 1;17(4):310-7. doi: 10.1001/journalofethics.2015.17.4.ecas3-1504. No abstract available.

9.

Can guidelines help reduce the medicalization of early childhood?

Graf WD, Singh I.

J Pediatr. 2015 Jun;166(6):1344-6. doi: 10.1016/j.jpeds.2015.03.049. Epub 2015 Apr 15. No abstract available.

PMID:
25890679
10.

Addressing the problem of ADHD medication as neuroenhancements.

Graf WD, Miller G, Nagel SK.

Expert Rev Neurother. 2014 May;14(5):569-81. doi: 10.1586/14737175.2014.908707. Epub 2014 Apr 17. Review.

PMID:
24738763
11.

No PEDs in pediatrics.

Graf WD, Epstein LG.

Pediatr Neurol. 2014 Apr;50(4):288-9. doi: 10.1016/j.pediatrneurol.2014.01.007. Epub 2014 Jan 8. No abstract available.

PMID:
24630279
12.

Author Response.

Graf WD, Nagel SK, Osnabruck N, Epstein LG, Miller G, Larriviere D.

Neurology. 2013 Oct 22;81(17):1558-9. No abstract available.

PMID:
24303531
13.

Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional deficiencies, and maternal illness.

Graf WD, Kekatpure MV, Kosofsky BE.

Handb Clin Neurol. 2013;111:143-59. doi: 10.1016/B978-0-444-52891-9.00014-2. Review.

PMID:
23622159
14.

Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.

Graf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D.

Neurology. 2013 Mar 26;80(13):1251-60. doi: 10.1212/WNL.0b013e318289703b. Epub 2013 Mar 13. Review.

PMID:
23486879
15.

Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome.

Le Pichon JB, Yu S, Kibiryeva N, Graf WD, Bittel DC.

Eur J Hum Genet. 2013 Oct;21(10):1093-9. doi: 10.1038/ejhg.2013.1. Epub 2013 Jan 30.

16.

Genomic disorders on chromosome 22.

Yu S, Graf WD, Shprintzen RJ.

Curr Opin Pediatr. 2012 Dec;24(6):665-71. doi: 10.1097/MOP.0b013e328358acd0. Review.

PMID:
23111679
17.

Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome.

Tate ED, Pranzatelli MR, Verhulst SJ, Markwell SJ, Franz DN, Graf WD, Joseph SA, Khakoo YN, Lo WD, Mitchell WG, Sivaswamy L.

J Child Neurol. 2012 Jul;27(7):875-84. doi: 10.1177/0883073811428816. Epub 2012 Feb 28. Erratum in: J Child Neurol. 2012 Oct;27(10):1364. Dosage error in article text.

PMID:
22378659
18.

BRAF gene deletion broadens the clinical spectrum neuro-cardio-facial-cutaneous syndromes.

Yu S, Graf WD.

J Child Neurol. 2011 Dec;26(12):1593-6. doi: 10.1177/0883073811413830. Epub 2011 Aug 23.

PMID:
21862832
19.

Identification of copy number variants on human chromosome 22 in patients with a variety of clinical findings.

Yu S, Graf WD, Ramalingam A, Brawner SJ, Joyce JM, Fiedler S, Zhou XG, Liu HY.

Cytogenet Genome Res. 2011;134(4):260-8. doi: 10.1159/000330123. Epub 2011 Aug 17.

PMID:
21849782
20.

Incidental neuroimaging findings in nonacute headache.

Graf WD, Kayyali HR, Abdelmoity AT, Womelduff GL, Williams AR, Morriss MC.

J Child Neurol. 2010 Oct;25(10):1182-7. doi: 10.1177/0883073809353149. Epub 2010 Aug 19.

PMID:
20724750
21.

Telomere capture as a frequent mechanism for stabilization of the terminal chromosomal deletion associated with inverted duplication.

Yu S, Graf WD.

Cytogenet Genome Res. 2010;129(4):265-74. doi: 10.1159/000315887. Epub 2010 Jul 6.

PMID:
20606397
22.

Genomic profile of copy number variants on the short arm of human chromosome 8.

Yu S, Fiedler S, Stegner A, Graf WD.

Eur J Hum Genet. 2010 Oct;18(10):1114-20. doi: 10.1038/ejhg.2010.66. Epub 2010 May 12.

23.
24.

Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Graf WD, Le Pichon JB, Bittel DC, Abdelmoity AT, Yu S.

Neurology. 2010 Mar 30;74(13):1080-1; author reply 1081. doi: 10.1212/WNL.0b013e3181d5e077. No abstract available.

PMID:
20350984
25.

B cell depletion therapy for new-onset opsoclonus-myoclonus.

Pranzatelli MR, Tate ED, Swan JA, Travelstead AL, Colliver JA, Verhulst SJ, Crosley CJ, Graf WD, Joseph SA, Kelfer HM, Raju GP.

Mov Disord. 2010 Jan 30;25(2):238-42. doi: 10.1002/mds.22941.

PMID:
20063398
26.

Neuroimaging-use trends in nonacute pediatric headache before and after clinical practice parameters.

Graf WD, Kayyali HR, Alexander JJ, Simon SD, Morriss MC.

Pediatrics. 2008 Nov;122(5):e1001-5. doi: 10.1542/peds.2008-1159. Epub 2008 Oct 6.

PMID:
18838461
27.

Cerebral dysgeneses secondary to metabolic disorders in fetal life.

Graf WD.

Handb Clin Neurol. 2008;87:459-76. doi: 10.1016/S0072-9752(07)87025-4. No abstract available.

PMID:
18809039
28.

Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy.

Kayyali HR, Abdelmoity AT, Morriss MC, Graf WD.

J Child Neurol. 2008 Mar;23(3):325-30. doi: 10.1177/0883073807309251. Epub 2008 Jan 9.

PMID:
18184936
29.

Stroke associated with central nervous system vasculitis after West Nile virus infection.

Alexander JJ, Lasky AS, Graf WD.

J Child Neurol. 2006 Jul;21(7):623-5.

PMID:
16970859
30.

Inborn errors of metabolism in infancy and early childhood: an update.

Raghuveer TS, Garg U, Graf WD.

Am Fam Physician. 2006 Jun 1;73(11):1981-90. Review.

31.

Intermediate filament proteinopathies: from cytoskeletons to genes to functional nosology.

Graf WD, Sarnat HB.

Neurology. 2002 May 28;58(10):1451-3. No abstract available.

PMID:
12034778
32.

Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism.

Graf WD, Unis AS, Yates CM, Sulzbacher S, Dinulos MB, Jack RM, Dugaw KA, Paddock MN, Parson WW.

Neurology. 2001 Aug 14;57(3):410-6.

PMID:
11502905
33.

Outcome of children after near drowning.

Graf WD, Quan L, Cummings P.

Pediatrics. 1998 Jan;101(1 Pt 1):160-1. No abstract available.

PMID:
11345984
34.

The study of neural tube defects after the Human Genome Project and folic acid fortification of foods.

Graf WD, Oleinik OE.

Eur J Pediatr Surg. 2000 Dec;10 Suppl 1:9-12. Review.

PMID:
11214847
35.

Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations.

Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ.

Neurology. 2001 Jan 23;56(2):260-3.

PMID:
11160968
36.

Can bioinformatics help trace the steps from gene mutation to disease?

Graf WD.

Neurology. 2000 Aug 8;55(3):331-3. Review. No abstract available.

PMID:
10932261
37.

Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation.

Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D, Barshop BA, Courchesne E, Haas RH.

J Child Neurol. 2000 Jun;15(6):357-61.

PMID:
10868777
38.

Brainstem diffusion-weighted MRI in boys with L1CAM mutations.

Graf WD, Born DE, Shaw DW, Thomas JR, Holloway LW, Michaelis RC.

Eur J Pediatr Surg. 1999 Dec;9 Suppl 1:41-2. No abstract available.

PMID:
10661793
39.

Diffusion-weighted magnetic resonance imaging in boys with neural cell adhesion molecule L1 mutations and congenital hydrocephalus.

Graf WD, Born DE, Shaw DW, Thomas JR, Holloway LW, Michaelis RC.

Ann Neurol. 2000 Jan;47(1):113-7.

PMID:
10632110
40.

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.

Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, Womble G, Risner M, Manasco P.

Neurology. 1999 Nov 10;53(8):1724-31.

PMID:
10563619
41.

Radical reactions from missing ceruloplasmin: the importance of a ferroxidase as an endogenous antioxidant.

Graf WD, Noetzel MJ.

Neurology. 1999 Aug 11;53(3):446-7. No abstract available.

PMID:
10449102
42.

Outcome in severe pediatric Guillain-Barré syndrome after immunotherapy or supportive care.

Graf WD, Katz JS, Eder DN, Smith AJ, Chun MR.

Neurology. 1999 Apr 22;52(7):1494-7.

PMID:
10227643
43.

The pachygyria-polymicrogyria spectrum of cortical dysplasia in X-linked hydrocephalus.

Graf WD, Born DE, Sarnat HB.

Eur J Pediatr Surg. 1998 Dec;8 Suppl 1:10-4.

PMID:
9926316
44.

Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy.

Graf WD, Oleinik OE, Glauser TA, Maertens P, Eder DN, Pippenger CE.

Neuropediatrics. 1998 Aug;29(4):195-201.

PMID:
9762695
45.

Ahomocysteinemia in molybdenum cofactor deficiency.

Graf WD, Oleinik OE, Jack RM, Weiss AH, Johnson JL.

Neurology. 1998 Sep;51(3):860-2.

PMID:
9748040
46.

Cell cycle properties in lymphocytes from children with myelomeningocele.

Graf WD, Oleinik OE.

Eur J Pediatr Surg. 1997 Dec;7 Suppl 1:15-7.

PMID:
9497110
47.

Uterine contraction in the development of Möbius syndrome.

Graf WD, Shepard TH.

J Child Neurol. 1997 Apr;12(3):225-7.

PMID:
9130101
48.

Plasma homocysteine and methionine concentrations in children with neural tube defects.

Graf WD, Oleinik OE, Jack RM, Eder DN, Shurtleff DB.

Eur J Pediatr Surg. 1996 Dec;6 Suppl 1:7-9.

PMID:
9008810
49.

Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.

Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD.

Cancer. 1996 Apr 1;77(7):1356-62.

PMID:
8608515
50.

Comparison of erythrocyte antioxidant enzyme activities and embryologic level of neural tube defects.

Graf WD, Oleinik OE, Pippenger CE, Eder DN, Glauser TA, Shurtleff DB.

Eur J Pediatr Surg. 1995 Dec;5 Suppl 1:8-11.

PMID:
8770569

Supplemental Content

Support Center